Yu Xia serves as Executive at Summit Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Yu Xia has executed 3 insider transactions totaling $57.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 21, 2025 involved purchasing 533,617 shares valued at $10.0M.
Yu Xia currently holds 32,057,147 shares of Summit Therapeutics Inc. (SMMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yu Xia has been a net buyer of SMMT stock. They have purchased $57.7M and sold $0 worth of shares.
Yu Xia's most recent insider trade was on Oct 21, 2025, when they purchased 533,617 shares at $18.74 per share.
Get notified when new Form 4 filings are submitted
| $1.05 |
| Discretionary |
| Jan 17, 2023 | SMMT | $25.1M | Purchase | 10,000,000 | $2.51 | Discretionary |